BridgeMD
New treatment option for Colorectal Cancer
Official title Prospective Study of Extended Robotic Right Hemicolectomy With Complete Mesocolic Excision for Cancer
ClinicalTrials.gov ID: NCT04190589
What this study is testing
- What it's testing
- A single-center prospective study to elucidate whether extended robot-assisted right colectomy (e-RARC) performs as well as extended open right colectomy (e-ORC) in terms of specimen quality, and in addition, whether less postoperative morbidity and shorter length of stay (LOS) can be attained. Patients with colonic cancer near the right flexure or the oral part of the transverse colon will be compared excluding the most technically demanding and frail patients in both groups.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Suspected or verified colonic cancer visualized by colonoscopy and on CT in the anal part of the ascending colon, in the right flexure or in the oral...
- Patient is 18 years or older, legally competent and able to comprehend information and give consent
- Tumor is UICC stage I-III on preop CT
- Operation is elective
You likely can't join if
- Previous major open intraabdominal surgery
- Ileus or other acute abdominal condition
- CT scan with suspicion of T4 tumor
- RITA score \> 3 (Preop risk and frailty score)
- BMI \> 35 kg/m2
- Project surgeon not available
The study team makes the final eligibility decision.
Where it's taking place
- Vejle, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vejle, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.